Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.

YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, Y...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1984
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC179968/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6097169/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.4.580
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!